XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Basic and Diluted Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Summary of basic and diluted income per share The following table sets forth the computation of basic and diluted net income per share:
(In thousands, except for share and per share amounts)Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Numerator:
Net income attributable to common stockholders—Basic$30,931$8,299$34,236$62,576
Net income attributable to common stockholders—Diluted$30,931$8,299$34,236$62,576
Denominator:
Weighted-average common shares outstanding—Basic (1)139,806,045138,061,829139,374,106137,348,180
Stock options2,893,3844,126,2563,451,2244,748,417
RSU awards4,1218,92946,84437,963
Weighted-average common shares outstanding—Diluted (1)142,703,550142,197,014142,872,174142,134,560
Net income per share—Basic$0.22$0.06$0.25$0.46
Net income per share—Diluted$0.22$0.06$0.24$0.44
(1)Excludes weighted-average Sponsor Vesting Shares subject to return of 4,500,000 shares as of September 30, 2023 and 2022.
Summary of Potentially Dilutive Securities for Common Stock The following potentially dilutive securities for common stock were outstanding and excluded from diluted earnings per share as they are subject to performance or market conditions that were not achieved as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Options to purchase common stock1,481,531 1,481,531 1,481,531 1,481,531 
Performance-based stock awards2,220,750 2,610,500 2,220,750 2,610,500 
Earnout shares25,000,000 25,000,000 25,000,000 25,000,000 
Sponsor vesting shares4,500,000 4,500,000 4,500,000 4,500,000 
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Warrants to purchase common stock35,476,627 35,476,627 35,476,627 35,476,627